Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Citalopram Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel process for cyanophthalide using sequential Grignard reagents offers safer, scalable route for antidepressant API manufacturing.
Discover the advanced preparation method for Citalopram intermediates described in patent CN1550497A, offering enhanced safety and cost reduction in pharmaceutical manufacturing.
Patent CN1423643A reveals a novel dehydration route for 5-cyanophthalide, offering significant cost reduction in API manufacturing and enhanced supply chain reliability for antidepressant production.
Deep dive into CN104072390B. Advanced impurity control for S-escitalopram. Reliable supply chain and cost-effective manufacturing solutions for global pharma.
Advanced enzymatic and chemical separation process for high-purity escitalopram intermediates. Reduces manufacturing costs and improves supply chain reliability for global API producers.
Patent CN1761658A details a novel solubility-based purification for 1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile, ensuring superior supply chain reliability.
Patent CN102796065A details a novel resolution and cyclization route for S-escitalopram, offering superior optical purity and simplified manufacturing for global pharmaceutical supply chains.
Patent CN1331686A details a novel dehydration route for 5-cyanophthalide, offering superior yields and eliminating heavy metal catalysts for cost-effective API manufacturing.
Patent CN111533662B details a cost-effective synthesis of citalopram intermediates using accessible halogenated benzoic acids, offering significant supply chain advantages.
Novel resolution method using ethyl acetate and ethanol mixtures ensures high optical purity and yield for scalable antidepressant intermediate production.